Cardiol Therapeutics Inc CRDL

Primary Symbol: T.CRDL Alternate Symbol(s): T.CRDL.W.A

Healthcare

Cardiol Therapeutics Inc. (Cardiol) is a Canada-based clinical-stage life sciences company focused on the research and clinical development of anti-inflammatory therapies for the treatment of cardiovascular disease (CVD). The Company's lead product, CardiolRx, is a pharmaceutically produced oral cannabidiol formulation that is in a Phase II/III study in hospitalized patients testing positive for COVID-19 with a prior history of, or risk factors for, cardiovascular disease. Cardiol has also received clearance from the Food and Drug Administration (FDA) for its investigational new drug (IND) application for a Phase II international trial that investigates the anti-inflammatory and anti- fibrotic properties of CardiolRx in patients with acute myocarditis, which is a common cause of sudden cardiac death in people under 35 years of age. In addition, Cardiol is developing a subcutaneous formulation of CardiolRx and other anti-inflammatory therapies for the treatment of chronic heart failure.

TSX:CRDL - Post by User

Cardiol Therapeutics Inc > This will recover. Hang tight IMHO

<< Previous

Bullboard Posts

Next >>

Post by Jordan1159on Jul 15, 2022 8:10am

428 Views

Post# 34826388

This will recover. Hang tight IMHO

When the dust settles, Cardiol Therapeutics will pop again back towards the $3.00 level. Still undervalued at that level in my opinion. Company is quiet until the markets settle down. Great management team. They have been here before. Not concerned. Possible buying op in front of us here. Don't lose the faith yet, you may regret it. Let's go!!!!

<< Previous

Bullboard Posts

Next >>

This life sciences company is gearing up to treat long COVID